TrialHealth and quality of life outcomes2013

Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension.

Hubert Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.